玻璃体腔注射Lucentis联合治疗增殖性糖尿病性视网膜病变合并虹膜新生血管的临床观察 Intravitreal Lucentis as a Adjuvant Treatment for Proliferative Diabetic Retinopaty Complicated with Iris Neovasucularization
Giuliari GP.Diabetic retinopathy:current and new treatment options[J].Curr Diabetes Rev,2012,8(1):32-41.
[2]
Sugiura Y,Okamoto F,Okamoto Y,et al.Ophthalmodynamometric pressure in eyes with proliferative diabetic retinopathy measured during pars plana vitrectomy[J].Am J Ophthalmol,2011,151(4):624-629.
[3]
Lüke J,Nassar K,Lüke M,et al.Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma—results from a prospective interventional case series[J].Graefes Arch Clin Exp Ophthalmol,2013,251(10):2 403-2 413.
[4]
Ishibashi S,Tawara A,Sohma R,et al.Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection[J].Arch Ophthalmol,2010,128(12):1 539-1 545.
[5]
Jiang Y,Liang X,Li X,et al.Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy[J].Arch Ophthalmol,2009,87(7):736-740.
[6]
乔斌,姚毅,赵晴阳.糖尿病视网膜病变玻璃体切除术后新生血管性青光眼原因分析[J].国际眼科杂志,2008,8(8):1584-1586.Qiao B,Yao Y,Zhao QY.Analysis on the factors of neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy[J].Int J Ophthalmol,2008,8(8):1 584-1 586.
[7]
Hufendiek K,Hufendiek K,Panagakis G,et al.Visual and morphological outcomes of bevacizumab(Avasin?)versus ranibizumab(Lucentis?)treatment for retinal angiomatous proliferation[J].Int Ophthalmol,2012,32(3):259-268.
[8]
Schmucker C,Antes G,Lelgemann M.Position Paper:The Need for Head-to-Head Studies Comparing Avastin versus Lucentis[J].Surv Ophthalmol,2009,54(6):705-707.
[9]
Asensio-Sánchez VM.Avastin is not the same as Lucentis,and Lucentis is not the same as Avastin[J].Arch Soc Esp Oftalmol,2009,84(9):427-428.
[10]
Al-Latayfeh M,Silva PS,Sun JK,et al.Antiangiogenic therapy for ischemic retinopathies[J].Cold Spring Harb Perspect Med,2012,2:(6):a006411.
[11]
Beutel J,Peters S,Lüke M,et al.Bevacizumab as adjuvant for neovascular glaucoma[J].Arch Ophthalmol,2010,88:103-109.
[12]
Lim TH,Bae SH,Cho YJ,et al.Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma[J].Korean J Ophthalmol,2009,23(3):188-192.
[13]
Kohno R,Hata Y,Mochizuki Y,et al.Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection[J].Am J Ophthalmol,2010,150(2):223-229.
